Programmed Cell Death Protein 4 (PDCD4) Antibody

Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Programmed Cell Death Protein 4 (PDCD4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx114697
tested applications
ELISA, WB, IHC

Description

Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) Antibody is a Rabbit Polyclonal antibody against Programmed Cell Death 4 (Neoplastic Transformation Inhibitor).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Programmed Cell Death Protein 4 (PDCD4)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q53EL6
Gene ID
27250
NCBI Accession
NP_055271.2, NM_014456.4, NP_663314.1, NM_145341.3
OMIM
608610
Background
Antibody anti-PDCD4
Status
RUO

Descripción

Related Products

EH2218

Human PDCD4 (Programmed cell death protein 4) ELISA Kit

Ver Producto
FNab06239

PDCD4 antibody

Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).

Ver Producto
FNab06240

PDCD4 antibody

Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).

Ver Producto